Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amplifon SpAAMFPY 60 EV-to-OCF is 10.13 as of Jul. 26, 2026, which is 48% below its 10-year median of 19.63. GuruFocus rates AMFPY with a GF Score™ of 60/100 and a GF Value™ of $170.39 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 119 Medical Distribution companies, Amplifon SpA ranks worse than 63.87% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Amplifon SpA's Enterprise Value is $4,778 Mil.
Amplifon SpA's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $472 Mil. Therefore, Amplifon SpA's EV-to-OCF for today is 10.13.
The historical rank and industry rank for Amplifon SpA's EV-to-OCF or its related term are showing as below:
AMFPY'
s EV-to-OCF Range Over the Past 10 Years
Min: 8.21 Med: 19.63 Max: 32.2
Current: 10.88
During the past 13 years, the highest EV-to-OCF of Amplifon SpA was 32.20. The lowest was 8.21. And the median was 19.63.
AMFPY's EV-to-OCF is ranked worse than 63.87% of 119
companies
in the Medical Distribution industry
Industry Median: 8.26
vs AMFPY: 10.88
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Amplifon SpA's PE Ratio (TTM) for today is calculated as:
Amplifon SpA's share price for today is $46.67.
Amplifon SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.434.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Amplifon SpA EV-to-OCF Related Terms
Amplifon SpA EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Amplifon SpA's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Amplifon SpA's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amplifon SpA EV-to-OCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amplifon SpA's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Amplifon SpA's EV-to-OCF falls into.
Amplifon SpA's current Enterprise Value is $4,778 Mil.
Amplifon SpA's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $472 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amplifon SpA (AMFPY) has a EV-to-OCF of 10.13 as of Jul. 26, 2026. This is 48% below median its historical median of 19.63. Over the past decade, Amplifon SpA's EV-to-OCF has ranged from 8.21 to 32.20. According to the industry distribution chart, Amplifon SpA ranks #76 out of 119 companies in the Medical Distribution industry, placing it in the top 63.9%.
Is Amplifon SpA's EV-to-OCF too high?
Amplifon SpA's current EV-to-OCF of 10.13 is 48% below median its 10-year median of 19.63. Over the past 10 years, this metric has ranged from a low of 8.21 to a high of 32.20. The Medical Distribution industry median EV-to-OCF is 8.26. Amplifon SpA's value of 10.13 is 22.6% above this industry median. Based on the distribution chart, Amplifon SpA ranks #76 out of 119 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Amplifon SpA has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Amplifon SpA's EV-to-OCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Amplifon SpA ranks #76 out of 119 companies for EV-to-OCF. This places Amplifon SpA in the lower half of its industry. The industry median EV-to-OCF is 8.26. Amplifon SpA's value of 10.13 is 22.6% above this benchmark. Historically, Amplifon SpA's own EV-to-OCF has ranged from 8.21 to 32.20 over the past decade. While the company's 10-year median is 19.63 vs. the industry median of 8.26, Amplifon SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Distribution company?
The median EV-to-OCF among Medical Distribution companies is 8.26, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amplifon SpA's current EV-to-OCF of 10.13 is 22.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median EV-to-OCF is 8.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amplifon SpA's current EV-to-OCF is 10.13, which is 48% below median its own 10-year median of 19.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amplifon SpA stock overvalued right now?
Based on GuruFocus' analysis, Amplifon SpA (AMFPY) is currently considered Possible Value Trap. The stock's GF Value™ is $170.39, compared to a current price of $46.67 — trading 72.6% below its estimated fair value. The current EV-to-OCF is 10.13, which is 48% below median its 10-year median of 19.63 and 22.6% above the Medical Distribution industry median of 8.26. Amplifon SpA's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Amplifon SpA (AMFPY), the current EV-to-OCF is 10.13 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amplifon SpA (AMFPY) Overvalued in 2026?
Based on GuruFocus' analysis, Amplifon SpA stock appears to be undervalued.
The current stock price of $46.67 is trading 72.6% below its estimated GF Value™ of $170.39.
GuruFocus considers Amplifon SpA to be Possible Value Trap.
Key valuation signals for AMFPY:
EV-to-OCF: 10.13 (48% below median its 10-year median of 19.63)
GF Value™: $170.39 vs. price of $46.67 (72.6% below fair value)
Industry Position: 22.6% above the Medical Distribution median (#76 of 119)
No single metric tells the full story. See the AMFPY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amplifon SpA provides customizable hearing solutions and services through a distribution network of network affiliates, corporate shops, franchises, and shop-in-shops. The company operates in three segments based on geography: the Americas; Europe, the Middle East, and Africa; and Asia-Pacific. It generates the majority of its revenue in the EMEA region. It operates under a variety of brands in these regions, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear.
60GF Score
Get the complete analysis for AMFPY
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMFPY has been successfully added to your 
